Inovio and ivi partner with seoul national university hospital to start phase 1/2 clinical trial of inovio's covid-19 dna vaccine (ino-4800) in south korea

Seoul, south korea and plymouth meeting, pa., june 4, 2020 /prnewswire/ -- inovio (nasdaq: ino), the international vaccine institute (ivi), and seoul national university hospital announced a partnership to start a phase 1/2 clinical trial of inovio's covid-19 vaccine ino-4800 in south...

INO Ratings Summary

INO Quant Ranking